OBP-2A inhibitors represent a class of chemical compounds that target and inhibit the activity of the enzyme Odorant-Binding Protein 2A (OBP-2A). OBP-2A is a member of the larger family of odorant-binding proteins, which are involved in the detection and transport of small volatile molecules, particularly odorants, in the olfactory system of vertebrates and insects. Structurally, OBP-2A is characterized by a beta-barrel fold, which forms a hydrophobic binding pocket capable of interacting with various hydrophobic ligands, including volatile compounds. Inhibitors of OBP-2A are designed to bind within this pocket, effectively blocking the interaction between OBP-2A and its natural ligands. This inhibition can lead to a reduced ability to capture and transport odorant molecules, affecting the downstream signaling events in olfactory pathways.
The design of OBP-2A inhibitors often revolves around mimicking the structure of the natural ligands, utilizing small hydrophobic molecules that can fit into the binding pocket with high affinity. The interaction of these inhibitors with OBP-2A is governed by non-covalent forces such as van der Waals interactions, hydrogen bonding, and hydrophobic effects. Researchers studying OBP-2A inhibitors typically investigate the binding kinetics and the structural compatibility of these molecules through techniques such as X-ray crystallography and molecular docking studies. The precise tuning of these interactions is critical to achieving selective inhibition, minimizing off-target effects, and gaining insight into the fundamental roles OBP-2A plays in molecular recognition and signaling pathways. The inhibition of such proteins provides a window into understanding molecular mechanisms underlying olfactory processing, which is crucial for elucidating broader biological systems.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $110.00 $250.00 $936.00 $50.00 | 33 | |
May modulate various signaling pathways, potentially affecting OBP-2A transcription. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Could inhibit protein synthesis, impacting OBP-2A protein levels. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
May inhibit RNA synthesis, affecting OBP-2A mRNA levels. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Could affect mTOR signaling, potentially influencing OBP-2A protein synthesis. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Might inhibit tyrosine kinases, potentially affecting signaling pathways influencing OBP-2A expression. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Could influence MAPK signaling, affecting OBP-2A expression. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Might affect JNK signaling, potentially influencing OBP-2A expression pathways. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Could inhibit PI3K, potentially affecting OBP-2A expression. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Might affect glucocorticoid-responsive elements, potentially influencing OBP-2A. | ||||||
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $138.00 $380.00 | 101 | |
Could cause DNA damage, potentially affecting OBP-2A transcription. | ||||||